Table 1.
Relationship in TCGA cohort between LPAR5 expression and clinicopathological features.
| Clinicopathologic features | Low expression (N=251) | High expression (N=251) | P value |
|---|---|---|---|
| Sex | 0.841 | ||
| Female | 185 | 182 | |
| Male | 66 | 69 | |
| Age | 0.089 | ||
| Mean±SD | 48.8±16.1 | 45.9±15.5 | |
| ≤45 | 143 | 123 | |
| >45 | 108 | 128 | |
| Histological type | <0.001* | ||
| Classical | 153 | 203 | |
| Other types | 98 | 48 | |
| Multi-nodularity | 0.352 | ||
| Yes | 112 | 124 | |
| No | 139 | 127 | |
| Tumor size (mm) | 0.875 | ||
| ≥20 | 230 | 228 | |
| <20 | 21 | 23 | |
| Lymph node metastasis | 0.003* | ||
| Yes | 120 | 154 | |
| No | 131 | 97 | |
| Distant metastasis | 0.177 | ||
| Yes | 118 | 102 | |
| No | 133 | 149 | |
| Disease stage (AJCC7) | 0.299 | ||
| I+II | 174 | 162 | |
| III+IV | 78 | 89 |
*
chi-square test;
*
p value <0.05